Moderna Inc
(XKAZ:MRNA_KZ)
$
94
0 (0%)
Market Cap: 15.50 Bil
Enterprise Value: 9.98 Bil
PE Ratio: 0
PB Ratio: 1.30
GF Score: 62/100 Moderna Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021 / 03:00PM GMT
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Okay. Good morning. Welcome to the last day of the Bank of America Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here at BofA. I also have Alec Stranahan from my team with me as well.
We're thrilled to have the Moderna team with us today for a session, and speaking on behalf of Moderna, we have CFO, Dave Meline. We also have Lavina Talukdar, who is Head of Investor Relations. Welcome, guys.
David W. Meline
Moderna, Inc. - CFO & Principal Accounting Officer
Good morning.
Lavina Talukdar
Moderna, Inc. - Senior VP & Head of IR
Good morning.
Geoffrey Christopher Meacham;David W. Meline
BofA Securities, Research Division - Research Analyst;
Yes. So we'll kick it off with David just giving us a couple of high-level comments post the quarter and an update, and then we'll get right into questions for Alec.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot